Average Co-Inventor Count = 7.12
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Schering Corporation (35 from 1,829 patents)
2. Merck Sharp + Dohme Corp. (16 from 2,405 patents)
3. Pharmacopeia Drug Discovery, Inc. (11 from 52 patents)
4. Pharmacopeia Inc. (3 from 101 patents)
5. Mochida Pharmaceutical Co., Ltd. (1 from 227 patents)
6. Msd R&d (china) Co., Ltd. (1 from 10 patents)
7. Schering Coporation (1 from 3 patents)
8. Msd R&d Co., Ltd. (0 patent)
52 patents:
1. 10646494 - Heterocycle-substituted tetracyclic compounds and methods of use thereof for the treatment of viral diseases
2. 10357481 - Substituted triazolo bicyclic compounds as PDE2 inhibitors
3. 10287293 - Bicyclic heterocyclic compounds as PDE2 inhibitors
4. 10174037 - Dihydropyrazolopyrimidinone compounds as PDE2 inhibitors
5. 10160762 - 6-alkyl dihydropyrazolopyrimidinone compounds as PDE2 inhibitors
6. 10138255 - Piperazine derivatives as HIV protease inhibitors
7. 9840478 - Piperazine derivatives as HIV protease inhibitors
8. 9254292 - Fused tetracycle derivatives and methods of use thereof for the treatment of viral diseases
9. 8987242 - Morpholinone compounds as factor IXA inhibitors
10. 8673924 - Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
11. 8642582 - Morpholinone compounds as factor IXa inhibitors
12. 8609676 - 4, 5, 6-trisubstituted pyrimidine derivatives as factor IXa inhibitors
13. 8603998 - Modulators of cell cycle checkpoints and their use in combination with checkpoint kinase inhibitors
14. 8586576 - Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors
15. 8580782 - Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors